DFTX:NASDAQ
Definium Therapeutics Inc
$37.99
arrow_downward
-0.63%(-0.24) 1D
$37.99
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 9, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$37.82
High
$38.93
Low
$37.68
Mkt. cap
5.10B
Avg. vol.
2.05M
Volume
1.29M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
Open
$37.82
High
$38.93
Low
$37.68
Mkt. cap
5.10B
Avg. vol.
2.05M
Volume
1.29M
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.23
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
Simply Wall Street
·
1 day ago
Does Breakthrough Therapy Status Change The Bull Case For Definium Therapeutics Stock (DFTX)?
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com